Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 22;7(7):494.
doi: 10.3390/jof7070494.

Antifungal Nano-Therapy in Veterinary Medicine: Current Status and Future Prospects

Affiliations
Review

Antifungal Nano-Therapy in Veterinary Medicine: Current Status and Future Prospects

Mousa A Alghuthaymi et al. J Fungi (Basel). .

Abstract

The global recognition for the potential of nanoproducts and processes in human biomedicine has given impetus for the development of novel strategies for rapid, reliable, and proficient diagnosis, prevention, and control of animal diseases. Nanomaterials exhibit significant antifungal and antimycotoxin activities against mycosis and mycotoxicosis disorders in animals, as evidenced through reports published over the recent decade and more. These nanoantifungals can be potentially utilized for the development of a variety of products of pharmaceutical and biomedical significance including the nano-scale vaccines, adjuvants, anticancer and gene therapy systems, farm disinfectants, animal husbandry, and nutritional products. This review will provide details on the therapeutic and preventative aspects of nanoantifungals against diverse fungal and mycotoxin-related diseases in animals. The predominant mechanisms of action of these nanoantifungals and their potential as antifungal and cytotoxicity-causing agents will also be illustrated. Also, the other theragnostic applications of nanoantifungals in veterinary medicine will be identified.

Keywords: mycotoxin degradation; nanoantifungal; theragnostic; veterinary.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Nanovehicles for effective and smart delivery of therapeutic drugs and other anti-fungal agents.
Figure 2
Figure 2
Various types of nano-based materials employed in antifungal nanotherapy in veterinary medicine.
Figure 3
Figure 3
Theragnostic applications of nanoantifungals in animal science.
Figure 4
Figure 4
Immuno-modulatory and other functions of nano-antifungals for cancer therapeutics.

Similar articles

Cited by

References

    1. Hassan A.A., Sayed-ElAhl R.M.H., Oraby N.H., El-Hamaky A.M.A. Nanomycotoxicology. Elsevier; Amsterdam, The Netherlands: 2020. Metal nanoparticles for management of mycotoxigenic fungi and mycotoxicosis diseases of animals and poultry; pp. 251–269.
    1. Tiew P.Y., Mac Aogain M., Ali N.A.B.M., Thng K.X., Goh K., Lau K.J.X., Chotirmall S.H. The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges. Mycopathologia. 2020;185:207–231. doi: 10.1007/s11046-019-00413-z. - DOI - PMC - PubMed
    1. Hassan A.A., Mansour M.K., Sayed-ElAhl R.M.H., El Hamaky A.M.A., Oraby N.H. Carbon Nanomaterials for Agri-Food and Environmental Applications. Elsevier; Amsterdam, The Netherlands: 2020. Toxic and beneficial effects of carbon nanomaterials on human and animal health; pp. 535–555.
    1. Fesseha H., Degu T., Getachew Y. Nanotechnology and its Application in Animal Production: A Review. Vet. Med. Open J. 2020;5:43–50. doi: 10.17140/VMOJ-5-148. - DOI
    1. Hassan A.A., Mansour M.K., El Hamaky A.M., Sayed-ElAhl R.M.H., Oraby N.H. Nanomaterials and Nanocomposite Applications in Veterinary Medicine. Elsevier; Amsterdam, The Netherlands: 2020.

LinkOut - more resources